Lawsuit for Investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) announced by the Shareholders Foundation
Investors who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) prior to October 2022 and continue to hold any of those NYSE: ATNM shares also have certain options and contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
On March 27, 2025, a NYSE: ATNM investor filed a lawsuit against Actinium Pharmaceuticals, Inc. over alleged violations of securities laws. The plaintiff alleged that the Defendants failed to disclose that the Company's data from the Sierra Trial was unlikely to satisfy the FDA's guidelines for the acceptance and approval of Iomab-B BLA, that the additional analyses, including long-term follow-ups that purportedly demonstrated a trend towards improved Overall Survival that the Company provided to the FDA in an attempt to mitigate Sierra's poor OS data were unlikely to satisfy the FDA's guidelines for the acceptance and approval of Iomab-B BLA, that as a result, the FDA would likely refuse to review the Iomab-B BLA or, if it did consider that BLA, that the application in its current form was unlikely to be approved, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
View original content to download multimedia: https://www.prnewswire.com/news-releases/lawsuit-for-investors-in-shares-of-actinium-pharmaceuticals-inc-nyse-atnm-announced-by-the-shareholders-foundation-302442087.html
SOURCE Shareholders Foundation, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Truist Slashes PT on Insperity (NSP) to $50 From $70
Insperity, Inc. (NYSE:NSP) is one of the best small cap low volatility stocks to invest in. Truist analyst Tobey Sommer lowered the firm's price target on Insperity, Inc. (NYSE:NSP) to $50 from $70 on August 4, keeping a Hold rating on the shares. A close-up of a hand signing a contract, symbolizing the legal agreement between employer and employee. The rating update followed the company's Q2 miss and guidance cut, which pointed towards the continued Workday expenses and the timing of roll-out, extending the transition period into FY26. The analyst told investors in a research note that another headwind for Insperity, Inc. (NYSE:NSP) is the benefits costs, resulting in FY25 EBITDA and EPS guidance being lowered. Insperity, Inc. (NYSE:NSP) provides human resources and business solutions that help enhance business performance. The company also offers employee benefits, payroll and employment administration, government compliance, workers' compensation, performance management, and more. While we acknowledge the potential of NSP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
31 minutes ago
- Yahoo
AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim
AT&T Inc. (NYSE:T) customers, both present and past, stand to receive up to $7,500 as part of a proposed $177 million settlement. This settlement is in response to two significant data breaches that affected millions of AT&T customers. What Happened: AT&T Inc. has suggested a settlement amounting to $177 million. This sum includes $149 million for the initial class-action lawsuit and an additional $28 million for the second one. The first data breach, revealed in March 2024, impacted 73 million account holders, with hackers obtaining personal information and disseminating it on the dark web. A subsequent breach in July 2024 compromised the call and text records of almost all AT&T customers. According to the report by New York Post, the settlement is yet to receive approval, with a final hearing set for December 3 in the US District Court for the Northern District of Texas. Customers who had their data compromised can apply for compensation before the hearing. They will be notified via an email from Kroll Settlement Administration and must submit a claim form by November 18. Also Read: GameStop to Pay $4.5 Million Over Alleged Privacy Violations Involving Facebook Data Sharing Customers affected by the March 2024 breach can claim up to $5,000, while those impacted by the July breach can claim up to $2,500. Customers who were affected by both breaches could be eligible for up to $7,500. AT&T will require evidence of losses associated with the breaches. Payouts are anticipated to commence by the end of the year, but may be postponed if appeals are lodged after the hearing. Why It Matters: This settlement proposal comes as a significant development for AT&T customers who were affected by the data breaches. The proposed compensation not only acknowledges the inconvenience and potential harm caused by the breaches, but also serves as a reminder of the importance of robust data security measures for companies handling sensitive customer information. The outcome of the final hearing will be closely watched, as it could set a precedent for future data breach settlements. Read Next Wall Street's Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks Delivering High-Dividend Yields UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? AT&T (T): Free Stock Analysis Report This article AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
41 minutes ago
- Yahoo
Benchmark Co. Maintains a Buy Rating on HNI Corporation (HNI)
HNI Corporation (NYSE:HNI) is one of the best small cap low volatility stocks to invest in. On August 5, Benchmark Co. analyst Reuben Garner maintained a Buy rating on HNI Corporation (NYSE:HNI) and set a price target of $60.00. A worker in a warehouse packaging a modern storage furniture. The rating update came after HNI Corporation (NYSE:HNI) announced on August 4 that it entered into a definitive agreement with Steelcase Inc. Under the terms of the agreement, HNI Corporation (NYSE:HNI) would acquire Steelcase in a 'cash and stock transaction, with a total consideration of approximately $2.2 billion to Steelcase common shareholders'. HNI Corporation (NYSE:HNI) provides workplace furnishings and residential building products. Its operations are divided into the Residential Building Products and Workplace Furnishing segments. The company's brand portfolio includes Beyond, HON, Kimball, HBF Textiles, HNI India, and more. Through its export subsidiary, HNI Corporation (NYSE:HNI) exports certain products to North America, principally Latin America, the Caribbean, and Mexico. While we acknowledge the potential of HNI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
